Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Cancer - OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer
Clinical Trial Research - Cardium Announces Planned Release of Data from Matrix Excellarate Phase 2b Clinical Study and Acceptance of Phase 1 / 2 Study for Publication in Wound Repair and Regeneration
Diarrhea - Newly Published Phase III Data Show Novartis Drug Sandostatin(R) LAR Depot Reduced Risk of Disease Progression by 66% in Advanced NET Patients
Hepatitis C Virus - InterMune Announces Initiation of Ritonavir-Boosted ITMN-191/RG7227 Study in HCV Patients
Plexxikon Inc. - Plexxikon Announces First Patient Dosed in First of Two Pivotal Trials of PLX4032 for Metastatic Melanoma
Stem Cell Research - Excellent Stem Cell Mobilization and Safety Profile for TG-0054
Acute Myeloid Leukemia - Studies from Johns Hopkins University provide new data on acute myeloid leukemia
Bacterial Vaginosis - New bacterial vaginosis study findings have been reported by scientists at University of California
Breast Cancer - New breast cancer research reported from University of Michigan, Medical Department
Cancer Vaccines - New cancer vaccines research from F.M. Lemoine and co-researchers described
Cancer Vaccines - Research from University of Wisconsin in the area of cancer vaccines described
Chronic Myeloid Leukemia - Study results from T. Hughes and colleagues broaden understanding of chronic myeloid leukemia
Colon Cancer - New colon cancer research reported from L. Claret and co-authors
Corneal Neovascularization - Studies from University of Erlangen further understanding of corneal neovascularization
Cystic Fibrosis - Study findings on cystic fibrosis are outlined in reports from N. Dauletbaev and colleagues
Glioblastoma - New glioblastoma data have been reported by S.A. Grossman and co-authors
Glioblastoma - Studies from G.G. Grabenbauer and co-researchers update current data on glioblastoma
Hepatitis C Virus - Research in the area of hepatitis C virus reported from University of Strasbourg
Life Sciences - Reports outline life sciences research from University of York
Liposarcoma - Reports by G.D. Demetri and co-researchers describe recent advances in liposarcoma
Macular Degeneration - Research from D.S. Boyer and colleagues has provided new data on macular degeneration
Melanoma - Report summarizes melanoma study findings from R.M. Eager and co-researchers
Mesothelioma - New data from University of Athens illuminate research in mesothelioma
Monoclonal Antibodies - Research data from University of Texas update understanding of monoclonal antibodies
Non-Small Cell Lung Cancer - New non-small cell lung cancer findings from A. Radhakrishnan and co-authors described
Non-Small Cell Lung Cancer - Research results from H. Borghaei and co-authors update knowledge of non-small cell lung cancer
Pancreatic Cancer - Research from University of Texas broadens understanding of pancreatic cancer
Pheochromocytoma - Research reports from University of California, Medical Department provide new insights into pheochromocytoma
Prostate Cancer - New prostate cancer study findings recently were reported by researchers at Stanford University
Renal Cell Carcinoma - New research on renal cell carcinoma from B. Escudier and co-authors summarized
Sarcoma - Research reports from A. Lashkari and co-authors provide new insights into sarcoma
Solid Cancer - New solid cancer study findings have been published by scientists at Erasmus University
Solid Cancer - Report summarizes solid cancer study findings from Case Western Reserve University
Advaxis, Inc. - Advaxis Secures $5.0 Million Investment
Affymax, Inc. - Affymax Secures $60 Million Issuer Managed Equity Facility with Azimuth Opportunity, Ltd.
Anavex Life Sciences Corp. - ANAVEX contracts FORENAP Pharma for clinical trials of ANAVEX 2-73 in Alzheimer's disease
Ardea Biosciences, Inc. - Ardea Biosciences to Present Results from a Phase 2a Study of RDEA594 at the 2009 ACR/ARHP Annual Scientific Meeting
Array BioPharma Inc. - Array BioPharma to Present Clinical Results on Diabetes Drug at European Diabetes Meeting
Bionovo, Inc. - Bionovo Announces Pricing of Securities Offering
Biothera - Imprime PGG(R) Named a Top 10 Oncology Drug Candidate for Partnering
Boehringer Ingelheim Pharmaceuticals, Inc. - Boehringer Ingelheim's Diabetes Pipeline Continues to Advance as the Company Announces Conclusion of Robust Phase III Clinical Program for linagliptin
Breast Cancer - Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cancer
Diabetes - InteKrin Therapeutics Presents Positive INT131 Phase 2b Results at the 45th Annual European Association for the Study of Diabetes Meeting
Diabetes - Intercept Pharmaceuticals' FXR Agonist INT-747 Meets Primary Endpoint in a Phase II Clinical Trial in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease
EnzymeRx, LLC - EnzymeRx Announces Its IND for Uricase-PEG 20 Becomes Effective
Genzyme Corporation - Genzyme's Campath Meets Primary Endpoint in Phase 3 Combination Therapy Trial for Chronic Lymphocytic Leukemia
Gout - BioCryst Announces Initiation of Phase 2 Study of BCX4208 for the Treatment of Gout
Halozyme Therapeutics, Inc. - Halozyme Begins Clinical Trial to Compare Three Insulin Analogs and Provides Update on Ultrafast Insulin Program
Halozyme Therapeutics, Inc. - Halozyme Presents Phase 2 Results for Regular Insulin-PH20 Confirming Faster Insulin Absorption and Superior Glucose Control
Head and Neck Cancer - Oncolytics Biotech(R) Inc. Reaches Special Protocol Assessment Agreement with the FDA on Design of Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
Heart Failure - Corthera's Relaxin Receives FDA Fast Track Designation for the Treatment of Acute Heart Failure
HIV/AIDS - Encouraging HIV/AIDS Vaccine Trial Results Support GeoVax Labs, Inc. Strategy
Idera Pharmaceuticals, Inc. - Idera Pharmaceuticals Presents Final Data from Phase 2 Clinical Trial of IMO-2055 Monotherapy in Renal Cell Carcinoma
Immunization - Medicago begins human clinical testing with its avian flu pandemic vaccine
Influenza - BioCryst Provides Update Regarding Peramivir for Influenza
LifeCycle Pharma A/S - LifeCycle Pharma Announces Positive Results from a 12 Month Extension Phase of the Phase 2 Clinical Study of LCP-Tacro(TM) Once Daily in Stable Liver Transplant Patients
Lung Cancer - Telik Announces Publication of Positive Phase 1-2a Results of a Multicenter Study of TELCYTA(R) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
Mid-Atlantic Bio - Top Bioscience Industry Leaders H. Tom Watkins and Tony Zook to Address Mid-Atlantic Bio Conference
Monoclonal Antibodies - Sanofi-aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM-121, an Anti-ErbB3 Monoclonal Antibody
Obesity and Diabetes - Data on VIVUS' Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting
Ocular Disease - MacuSight(R) Provides Clinical Development Update for Perceiva(TM)
Pfizer Oncology - Pfizer Launches Phase 3 Clinical Trial With Novel Alk Inhibitor In Non-Small Cell Lung Cancer Patients With Specific Gene Mutation
Pharmaceuticals - Alimera Reports Safety and Efficacy Results From the 18-Month Interim Readout of the Human PK Iluvien(R) Study
Pharmacokinetics - Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease
PolyMedix, Inc. - PolyMedix Initiates Dosing in Phase 1B Clinical Study of Novel Anticoagulant Antagonist Compound
pSivida Corp. - pSivida Reports Safety and Efficacy Results from 18-Month Interim Readout of Human PK Iluvien(R) Study
Psoriasis - Photos: STELARA(TM) (ustekinumab) Receives FDA Approval for Treatment of Moderate to Severe Plaque Psoriasis with Four-Times-A-Year Maintenance Dosing
Solid Cancer - Onyx Pharmaceuticals Initiates Phase 1 Study of ONX 0801 in Advanced Solid Tumors
Type 2 Diabetes - Intarcia Therapeutics, Inc. Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabetes Conference
Vertex Pharmaceuticals Incorporated - Vertex Pharmaceuticals Announces Publication of Telaprevir Abstracts for Presentation at the 60th AASLD Meeting
